Corbus Pharmaceuticals Holdings, Inc. Interest Expense
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Interest Expense of $652.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-06
- Corbus Pharmaceuticals Holdings, Inc. interest expense for the quarter ending 2024-06-30 was $652.00K, a 35.32% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. interest expense for the quarter ending 2023-06-30 was $1.01M.
- Corbus Pharmaceuticals Holdings, Inc. interest expense for the quarter ending 2016-03-31 was $6.43K, a 556.79% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. interest expense for the quarter ending 2015-12-31 was $1.07K, a 9.43% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. interest expense for fiscal 2015 was $2.44K, a 89.84% decline from fiscal 2014.
- Corbus Pharmaceuticals Holdings, Inc. interest expense for fiscal 2014 was $24.02K, a 46.75% decline from fiscal 2013.
- Corbus Pharmaceuticals Holdings, Inc. interest expense for fiscal 2013 was $45.11K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $652.00K 10-Q · filed 2024-08-06 | $1.49M 10-Q · filed 2024-08-06 | ||
| 2023-06-30 | $1.01M 10-Q · filed 2024-08-06 | $1.95M 10-Q · filed 2024-08-06 | ||
| 2016-03-31 | $6.43K 10-Q · filed 2016-05-13 | $7.50K derived: sum of 2 quarters · filed 2016-05-13 | $7.50K derived: sum of 3 quarters · filed 2016-05-13 | $7.89K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-12-31 | $1.07K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $1.07K derived: sum of 2 quarters · filed 2016-03-28 | $1.46K derived: sum of 3 quarters · filed 2016-03-28 | $2.44K 10-K · filed 2016-03-28 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 | $393.00 derived: sum of 2 quarters · filed 2015-11-10 | $1.37K 10-Q · filed 2015-11-10 | $2.35K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-06-30 | $393.00 10-Q · filed 2015-08-13 | $1.37K 10-Q · filed 2015-08-13 | $2.35K derived: sum of 3 quarters · filed 2016-05-13 | $3.00K derived: sum of 4 quarters · filed 2016-05-13 |
| 2015-03-31 | $979.00 10-Q · filed 2016-05-13 | $1.96K derived: sum of 2 quarters · filed 2016-05-13 | $2.60K derived: sum of 3 quarters · filed 2016-05-13 | $13.84K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $976.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $1.63K derived: sum of 2 quarters · filed 2016-03-28 | $12.86K derived: sum of 3 quarters · filed 2016-03-28 | $24.02K 10-K · filed 2016-03-28 |
| 2014-09-30 | $650.00 10-Q · filed 2015-11-10 | $11.88K derived: sum of 2 quarters · filed 2015-11-10 | $23.05K 10-Q · filed 2015-11-10 | $36.87K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $11.23K 10-Q · filed 2015-08-13 | $22.39K 10-Q · filed 2015-08-13 | $36.22K derived: sum of 3 quarters · filed 2015-08-13 | $45.58K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $11.16K 10-Q · filed 2015-05-13 | $24.98K derived: sum of 2 quarters · filed 2015-05-13 | $34.35K derived: sum of 3 quarters · filed 2015-05-13 | |
| 2013-12-31 | $13.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $23.19K derived: sum of 2 quarters · filed 2015-02-10 | $45.11K 10-K · filed 2015-02-10 | |
| 2013-09-30 | $9.37K 10-Q · filed 2014-11-13 | $31.29K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |